Kuhn, J M <br/><br/>
Pharmacokinetic and pharmacodynamic properties of a long-acting formulation of the new somatostatin analogue, lanreotide, in normal healthy volunteers.  [electronic resource] 

 -  British journal of clinical pharmacology  Sep 1994 
 - 213-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0306-5251 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2125.1994.tb04344.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abdominal Pain--chemically induced<br/>Amino Acid Sequence<br/>Analysis of Variance<br/>Antineoplastic Agents--administration & dosage<br/>Delayed-Action Preparations<br/>Diarrhea--chemically induced<br/>Glucagon--blood<br/>Growth Hormone--blood<br/>Humans<br/>Injections, Intramuscular<br/>Insulin--blood<br/>Insulin-Like Growth Factor I--metabolism<br/>Male<br/>Molecular Sequence Data<br/>Peptides, Cyclic--administration & dosage<br/>Prolactin--blood<br/>Radioimmunoassay<br/>Somatostatin--administration & dosage<br/>Thyroxine--blood